Search

everythinglearnresearchcommunity

for

Search:↓

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Trichoepitheliomas can be hard to distinguish from other skin conditions and often start in teenage years.

Some alternative therapies for vitiligo show promise but need more research.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Hydroxychloroquine may help treat alopecia areata in children.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Coloring white hair before IPL treatment effectively helps remove it.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Visual field defects in lupus nephritis can be caused by hypertensive retinopathy, not glaucoma or medication toxicity.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.